*(Via: HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved the first device aimed at preventing migraines.
The device, called Cefaly, is a headband-like device that runs on a battery and sits across the forehead and over the ears, the FDA said in a statement.
“The user positions the device in the center of the forehead, just above the eyes, using a self-adhesive electrode,” the agency explained. “The device applies an electric current to the skin and underlying body tissues to stimulate branches of the trigeminal nerve, which has been associated with migraine headaches.”
Cefaly is made by Belgium-based Cefaly Technology and is available by prescription only. The device is only indicated for use by adults and should only be used for 20 minutes per day, the FDA said. The agency also noted that “the user may feel a tingling or massaging sensation where the electrode is applied.”
Get MORE at HeatlthDay News.
Want to read more articles like this one? Subscribe to EURnewsletter.
Got A News Tip or Video You Want to Share? Contact us HERE.
- Beyoncé's Rep Responds to 'B.E.A.T.' Filmmakers 'Credit' Controversy
- What Should Society Do With An 11-Year-Old Murderer?
- Is This the REAL Reason Cam Walked Out of Press Conference? (WATCH)
- Misty Copeland's ‘Ballerina’s Tale’ Also Highlights the #BalletSoWhite Issue
- Ava DuVernay Being Courted to Direct Two Feature Films
- Taraji P. Henson Blames Coldplay/Maroon 5 Mixup on Her Friends (Watch)
- Gil Robertson: The 'African American Film Critics Association Awards' Interview with Kam Williams
- Flavor Flav Pleads No Contest in Vegas DUI Case
- ‘Black-ish’ To Address Police Brutality in Feb. 24 Episode
- J.Lo's 'Shades of Blue' Scores Second Season
- Discover More Stories on EURweb: Click Here